AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
QUALITY-OF-LIFE IN PATIENTS WITH NONCARDIAC CHEST PAIN EVALUATED IN AN EMERGENCY ROOM (ER)
Authors: SILMAN J KATZ P CASTELL D
Citation: J. Silman et al., QUALITY-OF-LIFE IN PATIENTS WITH NONCARDIAC CHEST PAIN EVALUATED IN AN EMERGENCY ROOM (ER), Gastroenterology, 114(4), 1998, pp. 169-169
DISTAL ESOPHAGEAL REFLUX ACCOMPANIES NOCTURNAL GASTRIC-ACID BREAKTHROUGH IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD) ON PROTON PUMP INHIBITOR (PPI) BID
Authors: ANDERSON C KATZ P KHOURY R CASTELL D
Citation: C. Anderson et al., DISTAL ESOPHAGEAL REFLUX ACCOMPANIES NOCTURNAL GASTRIC-ACID BREAKTHROUGH IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD) ON PROTON PUMP INHIBITOR (PPI) BID, Gastroenterology, 114(4), 1998, pp. 229-229
ANTIREFLUX THERAPY IMPROVES SYMPTOMS IN PATIENTS WITH REFLUX LARYNGITIS
Authors: GOVIL Y KATZ P SRINIVASAN R KHOURY R CASTELL D
Citation: Y. Govil et al., ANTIREFLUX THERAPY IMPROVES SYMPTOMS IN PATIENTS WITH REFLUX LARYNGITIS, Gastroenterology, 114(4), 1998, pp. 562-562
CISAPRIDE IMPROVES PULMONARY-FUNCTION TEST IN PATIENTS WITH GASTROESOPHAGEAL (GE) REFLUX AND CHRONIC RESPIRATORY SYMPTOMS
Authors: KHOURY R PAOLETTI V COHN J GIDEON M BRACY N KATZ P CASTELL D
Citation: R. Khoury et al., CISAPRIDE IMPROVES PULMONARY-FUNCTION TEST IN PATIENTS WITH GASTROESOPHAGEAL (GE) REFLUX AND CHRONIC RESPIRATORY SYMPTOMS, Gastroenterology, 114(4), 1998, pp. 712-712
INFLUENCE OF BODY POSITION ON NIGHTTIME RECUMBENT REFLUX IN PATIENTS WITH GERD
Authors: KHOURY R MOHIUDDIN M KATZ P CASTELL D
Citation: R. Khoury et al., INFLUENCE OF BODY POSITION ON NIGHTTIME RECUMBENT REFLUX IN PATIENTS WITH GERD, Gastroenterology, 114(4), 1998, pp. 713-713
ALOSETRON, A NEW 5HT3 ANTAGONIST HAS NO ADVERSE-EFFECTS ON ESOPHAGEALMOTILITY OR LOWER ESOPHAGEAL SPHINCTER (LES) PRESSURE
Authors: KHOURY R PEGHINI P KATZ P CASTELL D
Citation: R. Khoury et al., ALOSETRON, A NEW 5HT3 ANTAGONIST HAS NO ADVERSE-EFFECTS ON ESOPHAGEALMOTILITY OR LOWER ESOPHAGEAL SPHINCTER (LES) PRESSURE, Gastroenterology, 114(4), 1998, pp. 3199-3199
INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) - THE MOST COMMON MANOMETRIC ABNORMALITY IN GERD
Authors: BARRETT J PEGHINI P KATZ P CASTELL J CASTELL D
Citation: J. Barrett et al., INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) - THE MOST COMMON MANOMETRIC ABNORMALITY IN GERD, Gastroenterology, 112(4), 1997, pp. 66-66
PRIOR SENSITIZATION OF ESOPHAGEAL MUCOSA BY ACID REFLUX PREDISPOSES TO REFLUX INDUCED CHEST PAIN
Authors: BEEDASSY A KATZ P GRUBER A PEGHINI P CASTELL D
Citation: A. Beedassy et al., PRIOR SENSITIZATION OF ESOPHAGEAL MUCOSA BY ACID REFLUX PREDISPOSES TO REFLUX INDUCED CHEST PAIN, Gastroenterology, 112(4), 1997, pp. 69-69
CISAPRIDE 20 MG BID PROVIDES EFFECTIVE DAYTIME AND NIGHTTIME RELIEF IN PATIENTS WITH SYMPTOMS OF CHRONIC GASTROESOPHAGEAL REFLUX DISEASE
Authors: CASTELL D SIGMUND C PATTERSON D DIMICCO M BERENSON M LIEBERMANN T MELLOW M PRUITT R ERTAN A FARUQUI S LANZA F FITCH D SHAKER R MERRELL D HASNER D CLYDE C ZELDIS J
Citation: D. Castell et al., CISAPRIDE 20 MG BID PROVIDES EFFECTIVE DAYTIME AND NIGHTTIME RELIEF IN PATIENTS WITH SYMPTOMS OF CHRONIC GASTROESOPHAGEAL REFLUX DISEASE, Gastroenterology, 112(4), 1997, pp. 84-84
PNEUMATIC DILATATION (PD) IS EFFECTIVE PERMANENT TREATMENT FOR ACHALASIA
Authors: GILBERT J KATZ P CASTELL J CASTELL D
Citation: J. Gilbert et al., PNEUMATIC DILATATION (PD) IS EFFECTIVE PERMANENT TREATMENT FOR ACHALASIA, Gastroenterology, 112(4), 1997, pp. 125-125
INFLUENCE OF HEMODIALYSIS ON GASTROESOPHAGEAL REFLUX AND ESOPHAGEAL MOTILITY
Authors: HARTONO C PEGHINI P BERNS J CASTELL D
Citation: C. Hartono et al., INFLUENCE OF HEMODIALYSIS ON GASTROESOPHAGEAL REFLUX AND ESOPHAGEAL MOTILITY, Gastroenterology, 112(4), 1997, pp. 142-142
DIFFUSE ESOPHAGEAL SPASM (DES) INCLUDES 2 DISTINCT SUBGROUPS OF PATIENTS
Authors: PEGHINI P KATZ P SRINIVASAN R CASTELL J CASTELL D
Citation: P. Peghini et al., DIFFUSE ESOPHAGEAL SPASM (DES) INCLUDES 2 DISTINCT SUBGROUPS OF PATIENTS, Gastroenterology, 112(4), 1997, pp. 254-254
INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) IS A REPRODUCIBLE MANOMETRIC ENTITY, OCCURRING IN PATIENTS WITH GENERALLY LOW ESOPHAGEAL CONTRACTION AMPLITUDE
Authors: PEGHINI P KATZ P KO A GIDEON M CASTELL J CASTELL D
Citation: P. Peghini et al., INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) IS A REPRODUCIBLE MANOMETRIC ENTITY, OCCURRING IN PATIENTS WITH GENERALLY LOW ESOPHAGEAL CONTRACTION AMPLITUDE, Gastroenterology, 112(4), 1997, pp. 255-255
NOCTURNAL ACID BREAKTHROUGH DURING TWICE-DAILY (BID) ADMINISTRATION OF PROTON PUMP INHIBITOR (PPI)
Authors: PEGHINI P KATZ P BEDASSY A BRACY N GIDEON M PAOLETTI V CASTELL J CASTELL D
Citation: P. Peghini et al., NOCTURNAL ACID BREAKTHROUGH DURING TWICE-DAILY (BID) ADMINISTRATION OF PROTON PUMP INHIBITOR (PPI), Gastroenterology, 112(4), 1997, pp. 255-255
IMIPRAMINE INCREASES PAIN AND SENSATION THRESHOLDS TO ESOPHAGEAL BALLOON DISTENSION IN HUMANS
Authors: PEGHINI P KATZ P CASTELL D
Citation: P. Peghini et al., IMIPRAMINE INCREASES PAIN AND SENSATION THRESHOLDS TO ESOPHAGEAL BALLOON DISTENSION IN HUMANS, Gastroenterology, 112(4), 1997, pp. 255-255
LANSOPRAZOLE HEALS EROSIVE REFLUX ESOPHAGITIS RESISTANT TO HISTAMINE-H2-RECEPTOR ANTAGONIST THERAPY
Authors: SONTAG SJ KOGUT DG FLEISCHMANN R CAMPBELL DR RICHTER J ROBINSON M MCFARLAND M SABESIN S LEHMAN GA CASTELL D
Citation: Sj. Sontag et al., LANSOPRAZOLE HEALS EROSIVE REFLUX ESOPHAGITIS RESISTANT TO HISTAMINE-H2-RECEPTOR ANTAGONIST THERAPY, The American journal of gastroenterology, 92(3), 1997, pp. 429-437
THE DIAGNOSIS AND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN A MANAGED CARE ENVIRONMENT - SUGGESTED DISEASE MANAGEMENT GUIDELINES
Authors: FENNERTY MB CASTELL D FENDRICK AM HALPERN M JOHNSON D KAHRILAS PJ LIEBERMAN D RICHTER JE SAMPLINER RE
Citation: Mb. Fennerty et al., THE DIAGNOSIS AND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE IN A MANAGED CARE ENVIRONMENT - SUGGESTED DISEASE MANAGEMENT GUIDELINES, Archives of internal medicine, 156(5), 1996, pp. 477-484
EFFICACY AND SAFETY OF LANSOPRAZOLE IN THE TREATMENT OF EROSIVE REFLUX ESOPHAGITIS
Authors: CASTELL DO RICHTER JE ROBINSON M SONTAG SJ HABER MM ARORA S AVNER D BEHAR J WORTH H BRAZER S CAMPBELL D CASTELL D CHENG E EARNEST D FISHER R GASKINS R GERACI K GRAHAM D HARFORD W HOGAN W ISENBERG J JONES J KAHRILAS P KOGUT D KOVACS T LEHMAN G LEVINE D LOTT M MINER P MITTAL R MOVVA R PATTERSON D PLOTNICK B REDINGER R RICHTER J SABESIN S SAMPLINER R SCHLESINGER P SCHWARTZ J SHAH U SONTAG S SPECHLER S STRUM W TOSKES P TRUDEAU W VALENZUELA J VLAHCEVIC ZR
Citation: Do. Castell et al., EFFICACY AND SAFETY OF LANSOPRAZOLE IN THE TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, The American journal of gastroenterology, 91(9), 1996, pp. 1749-1757
SAFETY AND EFFICACY OF CONTROLLED-RELEASE MESALAMINE FOR MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS
Authors: MINER P HANAUER S ROBINSON M SCHWARTZ J ARORA S BRIGGS RL LAWLIS V FELGER C KITZMILLER G LIEBERMANN T FRACHTMAN R FISCHER C CELLO JP GRENDELL J SATOW J HANAUER SB HANAN I SCHULTZ P JAMES D MERTESDORF J HIESTAND F TUCKER P ROBERTS T BRUNDAGE P GRIFFIN T BECK JE RICK G HARTONG W BUSER W BRAND S BRYANT P KLIEWER M MELLOW M MCFADDEN R NEUMANN D HELIN K PRIVETTCOINTEPAS CJ MEEK RR ROUFAIL W BRICE R HUGHES TP FINA M MURPHY D CLINARD L ALLMAN D BOWEN B SCHWARTZ JL JURCIK I WHITE LB COHEN M SALES D GOCHNOUR S YORK NM WEINBERG D DUBOW RA PRIES J TOMBERS J GILBERSTADT S HANNA P WATSON MJ MATTISON M SAFDI M SAFDI A SCHNEIDER R WAISSBLUTH G KRAINES MD MAGAW L EMRATH N KAPLAN M MCKUSICK A ROSENBERG F KIRCH EP ALLEN HA WEBER B BARRIERO MA BANK L GITCHELL L STRUM WB GOODMAN L MATTER S MILLER D ANTONSON C CHRISTIAN R BIDDLE W CLARK S SUTTON DS KATON RM SMITH F BENNER K KEEFFE E LIEBERMAN D MELNYK C LINDENBURG F WEBSTER S ZFASS A KIRBY D LEE A YEE YS GOSHGARIANPATRICK P BARISH C ASHBURN P WATERMAN DC PATTERSON PM CARLISLE WR OUTIM L TOBIAS R COCHRAN JL BRISTOW WJ MILLER PD INGLE S KERR RM CASTELL D WU WC RICHTER JE GILLIAM JH STARK G LAW R MALONE N ROI L COEN M MOORE D MCPHERSON M
Citation: P. Miner et al., SAFETY AND EFFICACY OF CONTROLLED-RELEASE MESALAMINE FOR MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS, Digestive diseases and sciences, 40(2), 1995, pp. 296-304
NONSPECIFIC ESOPHAGEAL MOTILITY DISORDER (NEMD) IS PRIMARILY INEFFECTIVE ESOPHAGEAL MOTILITY (IEM)
Authors: LEITE L JOHNSTON B BARRETT J CASTELL J CASTELL D
Citation: L. Leite et al., NONSPECIFIC ESOPHAGEAL MOTILITY DISORDER (NEMD) IS PRIMARILY INEFFECTIVE ESOPHAGEAL MOTILITY (IEM), Gastroenterology, 108(4), 1995, pp. 147-147
IS OMEPRAZOLE RESISTANCE DUE TO MUTATIONS OF CYSTEINE 813 OR 822 IN THE ACID PUMP
Authors: LEITE L LAMBRECHT N SACHS G CASTELL D LAGERSTROM P
Citation: L. Leite et al., IS OMEPRAZOLE RESISTANCE DUE TO MUTATIONS OF CYSTEINE 813 OR 822 IN THE ACID PUMP, Gastroenterology, 108(4), 1995, pp. 147-147
THE HEALTH-RELATED QUALITY-OF-LIFE BENEFITS OF TREATMENT WITH LANSOPRAZOLE VERSUS OMEPRAZOLE FOR EROSIVE REFLUX ESOPHAGITIS
Authors: MATHIAS S CASTELL D ELKIN E LIBERMAN R
Citation: S. Mathias et al., THE HEALTH-RELATED QUALITY-OF-LIFE BENEFITS OF TREATMENT WITH LANSOPRAZOLE VERSUS OMEPRAZOLE FOR EROSIVE REFLUX ESOPHAGITIS, Gastroenterology, 108(4), 1995, pp. 160-160
DOES MUCOSAL ACID EXPOSURE SENSITIZE ESOPHAGEAL MECHANORECEPTORS
Authors: PEGHINI P LEITE L JOHNSTON B CASTELL D
Citation: P. Peghini et al., DOES MUCOSAL ACID EXPOSURE SENSITIZE ESOPHAGEAL MECHANORECEPTORS, Gastroenterology, 108(4), 1995, pp. 667-667
OMEPRAZOLE RESISTANCE IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Authors: JUST R GIDEON RM CASTELL D
Citation: R. Just et al., OMEPRAZOLE RESISTANCE IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD), Gastroenterology, 106(4), 1994, pp. 10000101-10000101
WHAT IS THE BEST ELECTRODE FOR MEASURING GASTRIC AND ESOPHAGEAL PH - A DIRECT COMPARISON OF GLASS AND ANTIMONY ELECTRODES
Authors: DEVAULT K DENUNA S GEORGESON S CASTELL D
Citation: K. Devault et al., WHAT IS THE BEST ELECTRODE FOR MEASURING GASTRIC AND ESOPHAGEAL PH - A DIRECT COMPARISON OF GLASS AND ANTIMONY ELECTRODES, Gastroenterology, 104(4), 1993, pp. 71-71
Risultati: 1-25 | 26-32